nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—pancreatic cancer	0.527	1	CbGaD
Clenbuterol—CYP1A1—Dacarbazine—pancreatic cancer	0.0864	0.261	CbGbCtD
Clenbuterol—CYP1A1—Tamoxifen—pancreatic cancer	0.0687	0.207	CbGbCtD
Clenbuterol—CYP1A1—Erlotinib—pancreatic cancer	0.0584	0.176	CbGbCtD
Clenbuterol—CYP1A2—Dacarbazine—pancreatic cancer	0.0386	0.116	CbGbCtD
Clenbuterol—CYP1A2—Tamoxifen—pancreatic cancer	0.0307	0.0926	CbGbCtD
Clenbuterol—CYP1A2—Erlotinib—pancreatic cancer	0.0261	0.0787	CbGbCtD
Clenbuterol—CYP1A2—Fluorouracil—pancreatic cancer	0.0226	0.0682	CbGbCtD
Clenbuterol—ADRB3—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.37e-05	0.000168	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCL8—pancreatic cancer	2.36e-05	0.000168	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	2.36e-05	0.000167	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	2.34e-05	0.000166	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	2.34e-05	0.000166	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	2.34e-05	0.000166	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP9—pancreatic cancer	2.34e-05	0.000166	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TYMP—pancreatic cancer	2.31e-05	0.000164	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	2.31e-05	0.000163	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SMAD4—pancreatic cancer	2.3e-05	0.000163	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	2.29e-05	0.000162	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCL8—pancreatic cancer	2.28e-05	0.000162	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CASP3—pancreatic cancer	2.26e-05	0.00016	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	2.25e-05	0.00016	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HES1—pancreatic cancer	2.25e-05	0.00016	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	2.24e-05	0.000159	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	2.2e-05	0.000156	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCND1—pancreatic cancer	2.2e-05	0.000156	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CTNNB1—pancreatic cancer	2.18e-05	0.000155	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—SRC—pancreatic cancer	2.16e-05	0.000153	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PIK3CB—pancreatic cancer	2.15e-05	0.000153	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	2.15e-05	0.000152	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—pancreatic cancer	2.14e-05	0.000152	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	2.14e-05	0.000151	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PTEN—pancreatic cancer	2.13e-05	0.000151	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	2.12e-05	0.00015	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	2.1e-05	0.000149	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—VEGFA—pancreatic cancer	2.1e-05	0.000149	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	2.09e-05	0.000148	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—STAT3—pancreatic cancer	2.08e-05	0.000148	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—NRAS—pancreatic cancer	2.08e-05	0.000147	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	2.08e-05	0.000147	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL8—pancreatic cancer	2.07e-05	0.000147	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	2.04e-05	0.000144	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	2.04e-05	0.000144	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	1.99e-05	0.000141	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	1.99e-05	0.000141	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SRC—pancreatic cancer	1.97e-05	0.00014	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TERT—pancreatic cancer	1.97e-05	0.00014	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.95e-05	0.000138	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TGFB1—pancreatic cancer	1.93e-05	0.000137	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—VEGFA—pancreatic cancer	1.92e-05	0.000136	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.91e-05	0.000135	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—STAT3—pancreatic cancer	1.9e-05	0.000135	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NRAS—pancreatic cancer	1.9e-05	0.000134	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—EGFR—pancreatic cancer	1.89e-05	0.000134	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HIF1A—pancreatic cancer	1.89e-05	0.000134	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TSC2—pancreatic cancer	1.88e-05	0.000133	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GLP1R—pancreatic cancer	1.87e-05	0.000132	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SST—pancreatic cancer	1.86e-05	0.000132	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APOE—pancreatic cancer	1.84e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.84e-05	0.00013	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—DPYD—pancreatic cancer	1.84e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	1.82e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SST—pancreatic cancer	1.82e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	1.82e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KDR—pancreatic cancer	1.8e-05	0.000128	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.8e-05	0.000127	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—KRAS—pancreatic cancer	1.79e-05	0.000127	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	1.78e-05	0.000126	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	1.78e-05	0.000126	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MYC—pancreatic cancer	1.77e-05	0.000125	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFB1—pancreatic cancer	1.76e-05	0.000125	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SLC2A2—pancreatic cancer	1.74e-05	0.000123	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EGFR—pancreatic cancer	1.73e-05	0.000123	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.72e-05	0.000122	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	1.72e-05	0.000122	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NFKBIA—pancreatic cancer	1.72e-05	0.000122	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NOTCH1—pancreatic cancer	1.7e-05	0.00012	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.69e-05	0.00012	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	1.68e-05	0.000119	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.67e-05	0.000118	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.66e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CG—pancreatic cancer	1.66e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—NRAS—pancreatic cancer	1.66e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	1.66e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGF—pancreatic cancer	1.64e-05	0.000116	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.63e-05	0.000116	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—KRAS—pancreatic cancer	1.63e-05	0.000116	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	1.62e-05	0.000115	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.62e-05	0.000115	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	1.58e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.58e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	1.56e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	1.55e-05	0.00011	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	1.53e-05	0.000108	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—HRAS—pancreatic cancer	1.52e-05	0.000108	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.52e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EGFR—pancreatic cancer	1.51e-05	0.000107	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PIK3CA—pancreatic cancer	1.5e-05	0.000106	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.48e-05	0.000105	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.47e-05	0.000104	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CD—pancreatic cancer	1.46e-05	0.000104	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—pancreatic cancer	1.45e-05	0.000103	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.45e-05	0.000103	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.44e-05	0.000102	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—KRAS—pancreatic cancer	1.43e-05	0.000101	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.41e-05	9.98e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HRAS—pancreatic cancer	1.39e-05	9.84e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.38e-05	9.77e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	1.37e-05	9.7e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.35e-05	9.59e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CD44—pancreatic cancer	1.35e-05	9.56e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—AKT1—pancreatic cancer	1.34e-05	9.51e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	1.34e-05	9.49e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	1.34e-05	9.47e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.32e-05	9.39e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.32e-05	9.36e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PIK3CA—pancreatic cancer	1.31e-05	9.31e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.31e-05	9.28e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	1.31e-05	9.26e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GCG—pancreatic cancer	1.29e-05	9.17e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.28e-05	9.07e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CB—pancreatic cancer	1.27e-05	9.02e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.25e-05	8.87e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	1.23e-05	8.71e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AKT1—pancreatic cancer	1.23e-05	8.69e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL8—pancreatic cancer	1.22e-05	8.67e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.22e-05	8.63e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—STK11—pancreatic cancer	1.22e-05	8.62e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HRAS—pancreatic cancer	1.22e-05	8.62e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	1.2e-05	8.52e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GLP1R—pancreatic cancer	1.19e-05	8.43e-05	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AKT1—pancreatic cancer	1.18e-05	8.38e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CASP3—pancreatic cancer	1.17e-05	8.3e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	1.17e-05	8.3e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—DPYD—pancreatic cancer	1.17e-05	8.3e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	1.14e-05	8.12e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.14e-05	8.09e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCND1—pancreatic cancer	1.14e-05	8.08e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CTNNB1—pancreatic cancer	1.13e-05	8e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	1.12e-05	7.93e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	1.12e-05	7.91e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.11e-05	7.87e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—pancreatic cancer	1.11e-05	7.84e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTEN—pancreatic cancer	1.1e-05	7.8e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.1e-05	7.79e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	1.09e-05	7.76e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	1.09e-05	7.75e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	1.09e-05	7.74e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AKT1—pancreatic cancer	1.07e-05	7.61e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	1.07e-05	7.59e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	1.07e-05	7.58e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.06e-05	7.52e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	1.05e-05	7.42e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TYMS—pancreatic cancer	1.05e-05	7.41e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SRC—pancreatic cancer	1.02e-05	7.23e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	1.02e-05	7.22e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	1.01e-05	7.15e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	9.96e-06	7.06e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VEGFA—pancreatic cancer	9.94e-06	7.04e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	9.86e-06	6.99e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	9.86e-06	6.99e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	9.86e-06	6.99e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—STAT3—pancreatic cancer	9.84e-06	6.97e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NRAS—pancreatic cancer	9.81e-06	6.96e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	9.75e-06	6.91e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.66e-06	6.85e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	9.65e-06	6.84e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	9.65e-06	6.84e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	9.53e-06	6.76e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MYC—pancreatic cancer	9.14e-06	6.48e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFB1—pancreatic cancer	9.12e-06	6.46e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	8.98e-06	6.37e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGFR—pancreatic cancer	8.94e-06	6.34e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	8.79e-06	6.23e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	8.67e-06	6.14e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CD44—pancreatic cancer	8.6e-06	6.1e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.59e-06	6.09e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOE—pancreatic cancer	8.5e-06	6.03e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	8.49e-06	6.02e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	8.48e-06	6.01e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KRAS—pancreatic cancer	8.45e-06	5.99e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.42e-06	5.97e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.4e-06	5.95e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.34e-06	5.91e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	8.3e-06	5.89e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GCG—pancreatic cancer	8.24e-06	5.84e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.05e-06	5.71e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	7.8e-06	5.53e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CA—pancreatic cancer	7.76e-06	5.5e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—STK11—pancreatic cancer	7.75e-06	5.49e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	7.68e-06	5.44e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	7.63e-06	5.41e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	7.56e-06	5.36e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—pancreatic cancer	7.51e-06	5.32e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARG—pancreatic cancer	7.41e-06	5.25e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	7.39e-06	5.24e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.28e-06	5.16e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	7.26e-06	5.15e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	7.21e-06	5.11e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HRAS—pancreatic cancer	7.18e-06	5.09e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	7.1e-06	5.03e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	7.06e-06	5e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	7.01e-06	4.97e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	6.95e-06	4.93e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	6.86e-06	4.86e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	6.8e-06	4.82e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	6.76e-06	4.8e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	6.75e-06	4.78e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	6.7e-06	4.75e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TYMS—pancreatic cancer	6.67e-06	4.73e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	6.62e-06	4.69e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	6.57e-06	4.66e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	6.55e-06	4.65e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	6.53e-06	4.63e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	6.42e-06	4.55e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	6.39e-06	4.53e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	6.37e-06	4.52e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AKT1—pancreatic cancer	6.34e-06	4.49e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	6.23e-06	4.42e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	6.05e-06	4.29e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	5.92e-06	4.2e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	5.9e-06	4.18e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	5.88e-06	4.17e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	5.84e-06	4.14e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—pancreatic cancer	5.83e-06	4.13e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	5.82e-06	4.13e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	5.77e-06	4.09e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	5.71e-06	4.05e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	5.7e-06	4.04e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	5.43e-06	3.85e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOE—pancreatic cancer	5.42e-06	3.84e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	5.41e-06	3.84e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	5.31e-06	3.76e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	5.31e-06	3.76e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	5.29e-06	3.75e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	5.19e-06	3.68e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.13e-06	3.64e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTEN—pancreatic cancer	5.08e-06	3.6e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	5.01e-06	3.55e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	4.9e-06	3.48e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	4.89e-06	3.47e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARG—pancreatic cancer	4.72e-06	3.35e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	4.61e-06	3.27e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	4.51e-06	3.19e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	4.46e-06	3.16e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	4.36e-06	3.09e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.3e-06	3.05e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	4.26e-06	3.02e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	4.17e-06	2.96e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	3.76e-06	2.67e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	3.75e-06	2.66e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—pancreatic cancer	3.72e-06	2.63e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	3.68e-06	2.61e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	3.59e-06	2.54e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.24e-06	2.3e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AKT1—pancreatic cancer	2.93e-06	2.08e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.29e-06	1.62e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.87e-06	1.32e-05	CbGpPWpGaD
